AKT1 and neoplasm: Intravital imaging of tumour xenografts confirmed that MEKi or a combined BRAFi + MEKi, increased ECM deposition and that persister cells were found adjacent to bundled collagen in vivo, which also increased the KIT-PI3K-AKT-mediated survival [114].